Feeling inspired to take these lessons back to my own work, making sure every experiment, every analysis, and every conclusion holds up to the highest standards. Here’s to doing great science, the right way! 💡🔬

Still buzzing from the Rigor in Research Workshop at Texas Biomed! @elisabethbik.bsky.social's comments on research ethics was a powerful reminder that great science isn’t just about discovery—it’s about trust, integrity, and repeatability. 🔬 #TexasBiomed #RigorInResearch #BlueSkyScience

Proud to be part of the worldwide effort to #EndTB through research and innovation. We have the tools to fight this, but we need more investment, awareness, and action. Let’s keep pushing.

Today is #WorldTBDay
TB is still a huge global health threat, hitting the most vulnerable communities the hardest. Treatments are tough, drug resistance is rising, and we still don’t have an effective vaccine—we need better solutions.
#TB #GlobalHealth #InfectiousDiseases #ScienceMatters

🚨1.25 million people died of TB in 2023
🚨10.8 million new cases of TB were diagnosed in 2023
🚨Multi-drug resistant TB is a public health crisis
🚨US$ 22 billion is needed annually for TB prevention, diagnosis, treatment and care, but funding is being cut.
🚨Poverty fuels TB globally
#WorldTBDay2025

Very excited to learn that @elisabethbik.bsky.social will be speaking at @txbiomed.bsky.social's upcoming Research Symposium! The work Dr. Bik has done to call out scientific misconduct and promote integrity is critical to advancing scientific research and gaining trust from non-scientists. 🔬🧪

I’m the Canadian who was detained by Ice for two weeks. It felt like I had been kidnapped — Guardian US I was stuck in a freezing cell without explanation despite eventually having lawyers and media attention. Yet, compared with others, I was lucky

You need to read this.

NIH centralizes peer review to improve efficiency and strengthen integrity The proposed approach is expected to save more than $65 million annually.

Goodbye study sections: www.nih.gov/news-events/...

Absence of c-Maf and IL-10 enables type I IFN enhancement of innate responses to LPS in alveolar macrophages Abstract. Alveolar macrophages (AMs) are lung-resident myeloid cells and airway sentinels for inhaled pathogens and environmental particles. While AMs can

So happy to share our latest paper on #AlveolarMacrophage responses to low-dose #LPS led by @pamelialim.bsky.social!AM #innate responses are enhanced by IFN-beta due to low c-Maf and IL-10 expression, with implications for AM responses to respiratory infections and environmental exposure. #ImmunoSky

Some good news! The final program for the inaugural #GRCBiologyofMycobacteria is up! We are also officially oversubscribed but cancellations happen... www.grc.org/biology-of-m...

Careers - Texas Biomed Join Texas Biomedical Research Institute today and enjoy making a difference in the health and wellbeing of others.

I’m devastated about layoffs of so many promising young scientists. We have a number of postdoc job openings at the Texas Biomedical Research Institute in addition to many other openings. Best of luck to those suddenly on the job market.
www.txbiomed.org/careers/

Inside the Collapse at NIH Administration officials pressured NIH to avoid clear advice from the agency’s own lawyers to restart grant funding now.

The Atlantic story on the situation at NIH is sobering. We are so screwed.

www.theatlantic.com/health/archi...

EVERYTHING IS TUBERCULOSIS | Kirkus Reviews A YA author uses his platform to tell the story of a curable disease that kills over a million people a year.

The first review of EVERYTHING IS TUBERCULOSIS is here and it's a **star** from Kirkus. (Mild spoilers ahead.) www.kirkusreviews.com/book-reviews...

Altered IL-6 signalling and risk of tuberculosis: a multi-ancestry mendelian randomisation study Our findings propose a causal relationship between reduced IL-6 signalling and lower risk of tuberculosis, akin to the effect seen in other IL-6 mediated diseases. This study suggests that IL-6 antago...

🚨 Delighted to share our paper defining a new role for IL-6 in TB. 🚨

We used genetic variation to show *reduced* IL-6 signalling is causally associated with *lower* risk of TB.

Lead author @gushamilton.bsky.social

#TBSky #IDSky #ImmunoSky www.thelancet.com/journals/lan...
Thread 👇 (1/8)

1/📢 In our new PREPRINT - tinyurl.com/yc6kbay9 - we estimate that 156 million people globally carry a recent, viable M. tuberculosis (Mtb) infection and are at high risk of progressing to TB disease.

This is great! Please add me, I'm new to bsky.